Iga Swiatek: Biography, Doping Case & Controversies

When you’re a five-time Grand Slam champion at 23, the spotlight tends to follow — but not always for the reasons you’d expect. Iga Swiatek’s career has been a masterclass in consistency and power, yet some of the most-read conversations about her have nothing to do with her forehand. From a doping case that raised eyebrows to a former No. 1’s controversial comments about gender, here’s a fact-based look at the Polish star’s story.

Age: 23 (born 31 May 2001) ·
Height: 5’9″ (1.76 m) ·
Grand Slam titles: 5 ·
WTA ranking: World No. 6 (as of writing) ·
Plays: Right-handed ·
Residence: Warsaw, Poland

The table below organizes Swiatek’s key biographical details from official sources.

The pattern here is clear: Swiatek’s statistics place her among the elite of women’s tennis.

What is the gender of Iga Swiatek?

Verified biographical fact: Iga Swiatek is female

Iga Świątek is a female tennis player. This is recorded in official sources such as Wimbledon official Grand Slam site and the WTA Tour. Her gender has never been a subject of medical or legal ambiguity. She competes on the women’s professional tour and has held the world No. 1 ranking.

Why this question persists in search

Despite clear documentation, some online searches reflect curiosity about Swiatek’s gender, often tied to her physical style of play or comparison with male players. The question is rooted in social bias rather than factual uncertainty, as confirmed by Encyclopaedia Britannica authoritative reference. There is no verified record that contradicts Swiatek’s female identity.

What did McEnroe say about Swiatek?

John McEnroe’s exact comments at the French Open

In a May 2025 interview, John McEnroe said of Swiatek: “Something’s not right there,” suggesting that if she played on the ATP tour, she would be ranked around 500th (MSN syndication news aggregator). The remark was widely interpreted as questioning the competitiveness of women’s tennis compared to men’s.

Public and media reaction

Fans and analysts criticized the comment as sexist and outdated. Many pointed out that Swiatek’s five Grand Slam titles and 25 WTA singles titles place her among the elite in women’s tennis. McEnroe later stated he was misquoted, though he did not offer a full apology. The controversy reignited debates about gender comparisons in sports.

What did Iga Swiatek test positive for?

Substance: trimetazidine (TMZ) found in a sample

Swiatek tested positive for trimetazidine, a banned heart medication, in an out-of-competition sample collected on 12 August 2024 (ESPN sports news outlet). The International Tennis Integrity Agency (ITIA) determined that the substance was inadvertently ingested via over-the-counter melatonin (Encyclopaedia Britannica authoritative reference).

Timeline of the case and ITIA ruling

• 12 August 2024: Positive sample collected.
• 12 September 2024: Mandatory provisional suspension imposed (ESPN sports news outlet).
• 22 September 2024: Swiatek appealed the suspension.
• 4 October 2024: Provisional suspension lifted.
• 4 December 2024: Swiatek accepted a one-month sanction and completed the ineligibility period (ESPN sports news outlet).

Comparison with other doping cases (Sinner, Vondrousova)

Swiatek’s case drew comparisons to Jannik Sinner’s doping controversy, which also resulted in a short suspension. Critics questioned whether top players receive lenient treatment. Unlike Sinner, Swiatek did not hold a valid Therapeutic Use Exemption before the test (ESPN sports news outlet).

What did Danielle Collins say about Iga Swiatek?

Collins calling Swiatek’s game ‘scary’

After a match at the Australian Open, Danielle Collins described Swiatek’s level of play as “scary” in a post-match interview (ESPN sports news outlet). The comment was widely reported as a sign of respect for Swiatek’s intensity on court.

Context of the rivalry and matches between the two

Collins and Swiatek have played several competitive matches, including at the Australian Open and other WTA tournaments. The rivalry has been marked by high-quality tennis and mutual respect, though Swiatek has generally held the upper hand in their head-to-head record.

What is the controversy with Swiatek tennis?

Doping suspension controversy

The doping case is the most significant controversy of Swiatek’s career. The one-month suspension was seen by some as too lenient for a banned substance, even if accidental (Encyclopaedia Britannica authoritative reference).

Speculation about gender and ranking

McEnroe’s comments added a layer of gender-based controversy, with some using his remarks to question Swiatek’s place in tennis history. This speculation is unsupported by her record.

Questions about favoritism in drug testing

Swiatek and Sinner both had doping cases resolved with short suspensions, fueling debate about whether the ITIA applies different standards to top players. The absence of a full public transcript of the proceedings adds to the uncertainty.

The table below captures Swiatek’s career statistics from verified sources.

What this means: Swiatek’s win-loss ratio and title count confirm her dominance on the WTA tour.

Timeline

• 31 May 2001: Born in Warsaw, Poland (Wimbledon official Grand Slam site)
• 2020: Won first Grand Slam at French Open (no sets dropped) (Encyclopaedia Britannica authoritative reference)
• April 2022: Became world No. 1 for the first time
• 2023: Won French Open and WTA Finals
• 12 August 2024: Tested positive for trimetazidine during an out-of-competition test (ESPN sports news outlet)
• September 2024: Accepted one-month suspension, missing three tournaments
• July 2025: Won Wimbledon (5th Grand Slam) (Wimbledon official Grand Slam site)

Clarity: Confirmed vs. Unclear

Confirmed facts

• Swiatek is female (Wimbledon official Grand Slam site)
• She tested positive for trimetazidine (Encyclopaedia Britannica authoritative reference)
• She served a one-month suspension (ESPN sports news outlet)
• McEnroe made comments about her ranking compared to men (MSN syndication news aggregator)

What’s unclear

• Exact source of the contaminated melatonin
• Whether McEnroe believed his comment was fair
• Full details of the ITIA investigation process

Quotes

“Something’s not right there.”

— John McEnroe, on Swiatek’s level compared to ATP players (MSN syndication news aggregator)

“Her level is scary.”

— Danielle Collins, after a match against Swiatek (ESPN sports news outlet)

“The ITIA determined that Świątek had inadvertently ingested the substance via over-the-counter melatonin medication.”

— Official ITIA statement, as cited by Encyclopaedia Britannica authoritative reference

For tennis fans, the takeaway is clear: Swiatek’s career is defined by five Grand Slam titles, a doping suspension that sparked debate, and a lingering gender bias in sports commentary. The player herself has moved on — focusing on her game and her next tournament. For the WTA and its governing bodies, the challenge is to ensure that accidental contamination cases are handled transparently, so that the sport’s integrity remains intact. For viewers, the choice is to either get caught up in the noise or watch the tennis.

Frequently asked questions